Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success. They specifically apply its approach to challenging oncology drug targets causally implicated in the vast majority of cancers, particularly those without simple single-gene driver mutations or synthetic lethal contexts. The company aims to rapidly progress in-licensed clinical-stage assets and a pipeline of internally developed programs through accelerated registration trials.
Domain
acrivon.com
Country
United StatesIndustry
BiotechnologyEmployees
51-100
Last Funding
$130.0M
Founded
2017
Tech Stack (16 technologies)
Frequently Asked Questions
What technologies does Acrivon Therapeutics use?+
Acrivon Therapeutics uses 16 technologies including GDPR Cookie Consent Plugin by Webtoffee, Google Analytics, Google Tag Manager.
What industry is Acrivon Therapeutics in?+
Acrivon Therapeutics operates in the Biotechnology industry.
Where is Acrivon Therapeutics based?+
Acrivon Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026